Circadian Rhythms and Cardiovascular Risk



Status:Recruiting
Conditions:Insomnia Sleep Studies, Pulmonary
Therapuetic Areas:Psychiatry / Psychology, Pulmonary / Respiratory Diseases
Healthy:No
Age Range:40 - 80
Updated:2/8/2019
Start Date:August 2014
End Date:December 2019
Contact:Saurabh Thosar, PhD
Email:circadian@ohsu.edu
Phone:503-346-3808

Use our guide to learn which trials are right for you!

The purpose of this study is to understand how behaviors and the effects of the body's
internal clock (called the circadian pacemaker) affect the control of the heart and blood
pressure.

People with Obstructive Sleep Apnea (OSA) are hypothesized to have altered circadian
amplitudes in certain key indices of cardiovascular (CV) and an abnormally advanced circadian
phase in some of the same key indices of CV risk. The investigators hypothesize that such
changes, taken together, may explain the different timing of heart attack and sudden cardiac
death in OSA.


- BMI less than 40

- Moderate to severe OSA (AHI)>15

- No current or previous pharmacological treatment for hypertension
We found this trial at
1
site
3181 Southwest Sam Jackson Park Road
Portland, Oregon 97239
503 494-8311
Principal Investigator: Steven A Shea, PhD
Phone: 503-346-3808
Oregon Health and Science University In 1887, the inaugural class of the University of Oregon...
?
mi
from
Portland, OR
Click here to add this to my saved trials